Project Serotonin launches Preventive Health Platform
Analysis based on 8 articles · First reported Aug 10, 2026 · Last updated Aug 13, 2026
The launch of Project Serotonin's preventive health platform could influence the healthcare technology sector by promoting integrated, data-driven preventive care solutions. While the company is private and not publicly traded, its platform may create competitive pressure and opportunities for partnerships within the healthcare industry.
Project Serotonin, a preventive health technology company based in San Francisco and Bengaluru, announced the launch of its tenth-generation Preventive Health Platform and Precision Health OS at the RISE for Healthy Aging, the Longevity India Conference held at the Indian Institute of Science in Bengaluru. The platform is designed to enable hospitals, clinic networks, and longevity centers to deliver continuous, personalized preventive care by integrating fragmented health data such as diagnostics, genomics, blood biomarkers, wearable data, and clinical records into a unified model. The Precision Health OS evaluates individual health profiles and translates them into structured protocols via the SRTN Precision Daily Operating System, drawing on an evidence base of over 44,000 clinical studies. The platform includes twelve integrated systems, including a clinician console and Rx Intelligence screened against more than 2,600 drugs. Project Serotonin aims to complement existing healthcare infrastructure, allowing institutions to adopt modular capabilities. The company has invested over 300,000 hours in R&D and conducted real-world pilots for its protocols.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard